Label: FEXOFENADINE HCL tablet, film coated
-
NDC Code(s):
50228-201-01,
50228-201-02,
50228-201-03,
50228-201-04, view more50228-202-01, 50228-202-02, 50228-202-03, 50228-202-04
- Packager: ScieGen Pharmaceuticals, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated January 19, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- HIVESActive ingredient (in each film-coated tablet)
- Purpose
- INDICATIONS & USAGE
-
Warnings
Severe Allergy Warning: Get emergency help immediately if you have hives along with any of the following symptoms:
- trouble swallowing
- dizziness or loss of consciousness
- swelling of tongue
- swelling in or around mouth
- trouble speaking
- drooling
- wheezing or problems breathing
These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health profession immediately. Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later.
Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrine injector for "anaphylaxis" or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times.
Do not use
to prevent hives from any known cause such as:
- foods
- insect stings
- medicines
- latex or rubber gloves
because this product will not stop hives from occurring. Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a cause.
•If you have ever had an allergic reaction to this product or any of its ingredients
Ask a doctor before use if you have
- •
- kidney disease.Your doctor should determine if you need a different dose.
- •
- hives that are an unusual color, look bruised or blistered
- •
- hives that do not itch
When using this product
- do not take more than directed
- do not take at the same time as aluminum or magnesium antacids
- do not take with fruit juices (see Directions)
- Directions (for 60mg)
- Directions (for 180mg)
- Other information
- Inactive ingredients
- Questions or comments?
- ALLERGYActive ingredient (in each film-coated tablet)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
kidney disease. Your doctor should determine if you need a different dose.
When using this product
- do not take more than directed
- do not take at the same time as aluminum or magnesium antacids
- do not take with fruit juices (see Directions)
- Directions (for 60mg)
- Directions (for 180mg)
- Other information
- Inactive ingredients
- Questions or comments?
- PRINCIPAL DISPLAY PANEL
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
- Package/Label Principal Display Panel
-
INGREDIENTS AND APPEARANCE
FEXOFENADINE HCL
fexofenadine hcl tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50228-201 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE 60 mg Inactive Ingredients Ingredient Name Strength ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STARCH, CORN (UNII: O8232NY3SJ) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) STEARIC ACID (UNII: 4ELV7Z65AP) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) FERRIC OXIDE RED (UNII: 1K09F3G675) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) Product Characteristics Color PINK Score no score Shape OVAL Size 12mm Flavor Imprint Code SG;201 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50228-201-01 30 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 2 NDC:50228-201-02 1000 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 3 NDC:50228-201-03 30 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 4 NDC:50228-201-04 1000 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204507 12/26/2014 FEXOFENADINE HCL
fexofenadine hcl tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50228-202 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE 180 mg Inactive Ingredients Ingredient Name Strength ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STARCH, CORN (UNII: O8232NY3SJ) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) STEARIC ACID (UNII: 4ELV7Z65AP) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) FERRIC OXIDE RED (UNII: 1K09F3G675) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) Product Characteristics Color PINK Score no score Shape CAPSULE Size 17mm Flavor Imprint Code SG;202 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50228-202-01 30 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 2 NDC:50228-202-02 1000 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 3 NDC:50228-202-03 30 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 4 NDC:50228-202-04 1000 in 1 BOTTLE; Type 0: Not a Combination Product 12/26/2014 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204507 12/26/2014 Labeler - ScieGen Pharmaceuticals, Inc. (079391286) Registrant - ScieGen Pharmaceuticals, Inc. (079391286) Establishment Name Address ID/FEI Business Operations ScieGen Pharmaceuticals, Inc. 079391286 ANALYSIS(50228-201, 50228-202) , MANUFACTURE(50228-201, 50228-202) , PACK(50228-201, 50228-202) , LABEL(50228-201, 50228-202)